ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670995; 2) Community: the network communities that were significantly associated with the response to NSC 670995; 3) Molecule: the relationships between components within communities and NSC 670995; 4) MDR: the compounds that were significantly associated with the NSC 670995.

NSC Compound Enrichment Correlation
NSC 740 Methotrexate 0.0016558732586581 0.43059345
NSC 743528 Null 0.0016558732586581 0.42674944
NSC 743530 Null 0.0016558732586581 0.46262134
NSC 743876 Null 0.0016558732586581 0.32751303
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0016558732586581 0.46532574
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.00180888338647612 0.45443053
NSC 374998 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyrimidinyl)ethylidene] hydrazide 0.00180888338647612 0.41662857
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.00180888338647612 -0.19054189
NSC 628917 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide 0.00180888338647612 0.65388085
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.00180888338647612 0.50238063
Total:148  Current:20    [First] [Prev] [Next] [Last]